Abcuro, ImaginAb tout Immuno-PET study results

By staff writers

June 30, 2021 -- Abcuro and ImaginAb are highlighting the results of a study using the Immuno-PET radiotracer to show that CD8+ T-cells are present throughout the skeletal muscle system in patients with inclusion body myositis (IBM).

ImaginAb's antibody-fragment imaging technology offers a more comprehensive view of T-cell infiltration than muscle biopsies provide. The Immuno-PET technology binds to and lights up the specific immune cell type that is central to the etiology of IBM.

Viewing the entire spectrum of skeletal muscle allowed Abcuro to assess the presence of CD8+ T-cells prior to dosing patients with the therapeutic agent ABC008, according to the results.

Copyright © 2021

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking